Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Turning Point Therapeutics

7 Disclosed Funding Rounds $720,709,731

0 Participating Investments


Pharmaceutical, Therapeutics, Health Care, Biotechnology

Turning Point Therapeutics is a structure-based drug design pharmaceutical company.

San Diego, California, United States, North America (US)

Organizations in San Diego in Pharmaceutical,
Organizations in San Diego in Therapeutics,
Organizations in San Diego in Health Care,
Organizations in San Diego in Biotechnology,
Organizations in California in Pharmaceutical,
Organizations in California in Therapeutics,
Organizations in California in Health Care,
Organizations in California in Biotechnology,
Organizations in United States in Pharmaceutical,
Organizations in United States in Therapeutics,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in North America in Pharmaceutical,
Organizations in North America in Therapeutics,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology

Investors in San Diego in Pharmaceutical,
Investors in San Diego in Therapeutics,
Investors in San Diego in Health Care,
Investors in San Diego in Biotechnology,
Investors in California in Pharmaceutical,
Investors in California in Therapeutics,
Investors in California in Health Care,
Investors in California in Biotechnology,
Investors in United States in Pharmaceutical,
Investors in United States in Therapeutics,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in North America in Pharmaceutical,
Investors in North America in Therapeutics,
Investors in North America in Health Care,
Investors in North America in Biotechnology

Greater San Diego Area (0 Investors) (0 Startups), West Coast (0 Investors) (0 Startups), Western US (0 Investors) (0 Startups)

Founded date 10, 2013

Founders Y. Peter Li, J. Jean Cui

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Also known as TP Therapeutics, Turning Point Tx

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Turning Point Therapeutics, Inc. is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.

Date Round Raised Lead
May, 18, 2020 Post-IPO Equity $373,800,000 -------
September, 16, 2019 Post-IPO Equity $202,500,000 -------
October, 19, 2018 Series D $80,000,000 Foresite Capital, venBio Partners
May, 23, 2017 Series C $45,000,000 SR One, Lilly Asia Ventures, OrbiMed
March, 21, 2016 Venture - Series Unknown $17,979,732 -------
July, 28, 2015 Series B Undisclosed -------
January, 06, 2014 Venture - Series Unknown $1,429,999 -------

Turning Point Therapeutics Investors (15)

Investor Lead? Round Participating Raise Date Partners
HBM Healthcare Investments AG No Series D $80,000,000 October, 19, 2018 -------
Foresite Capital Yes Series D $80,000,000 October, 19, 2018 -------
Cormorant Asset Management No Series D $80,000,000 October, 19, 2018 -------
Lilly Asia Ventures No Series D $80,000,000 October, 19, 2018 -------
venBio Partners Yes Series D $80,000,000 October, 19, 2018 -------
Nextech Invest No Series D $80,000,000 October, 19, 2018 -------
SR One No Series D $80,000,000 October, 19, 2018 -------
Kenson Ventures No Series D $80,000,000 October, 19, 2018 -------
OrbiMed No Series D $80,000,000 October, 19, 2018 -------
SR One Yes Series C $45,000,000 May, 23, 2017 -------
Cormorant Asset Management No Series C $45,000,000 May, 23, 2017 -------
Lilly Asia Ventures Yes Series C $45,000,000 May, 23, 2017 -------
OrbiMed Yes Series C $45,000,000 May, 23, 2017 -------
SV Tech Ventures No Series C $45,000,000 May, 23, 2017 -------
CRCM Ventures No Series B Undisclosed July, 28, 2015 -------

Turning Point Therapeutics in the News